Effects of Mirabegron on Anxiety and Depression in Female Patients with Overactive Bladder

Manami Kinjo1, Tsuyoshi Yamaguchi2, Mitsuhiro Tambo2

  • 1Department of Urology, Kyorin University School of Medicine, Tokyo, Japan, kinjo_1702@yahoo.co.jp.

Urologia Internationalis
|February 26, 2019
PubMed
Abstract

Insights

Mirabegron effectively treated overactive bladder (OAB) symptoms, significantly improving anxiety in women. While OAB symptom improvement correlated with reduced anxiety, it did not significantly impact depression.

Area of Science:

  • Urology
  • Psychiatry
  • Pharmacology

Background:

  • Antimuscarinic agents for overactive bladder (OAB) may improve co-occurring depression and anxiety.
  • Mirabegron is a beta-3 adrenergic agonist used for OAB treatment.
  • The relationship between OAB symptom management and mental health requires further investigation.

Purpose of the Study:

  • To assess mirabegron's efficacy on OAB symptoms in treatment-naïve women.
  • To evaluate mirabegron's impact on anxiety and depression symptoms in this patient group.
  • To explore correlations between OAB symptom improvement and changes in anxiety/depression.

Main Methods:

  • Prospective evaluation of 112 women with OAB treated with mirabegron.
  • Assessment using Overactive Bladder Symptom Score (OABSS) and Hospital Anxiety and Depression Scale (HADS) at baseline, 4, and 8 weeks.
  • Statistical analysis included Wilcoxon signed-rank test and Spearman rank correlation.

Main Results:

  • Significant improvements in OAB, anxiety, and depression symptom scores were observed at 4 and 8 weeks (p < 0.05).
  • Prevalence of clinical anxiety and depression at baseline was 25.0% and 22.3%, respectively.
  • Anxiety symptoms showed a significant correlation with OAB symptoms, but depression symptoms did not.

Conclusions:

  • Mirabegron treatment improves OAB symptoms and associated anxiety.
  • The study suggests that alleviating OAB symptoms can positively impact anxiety levels.
  • Mirabegron's effect on depression symptoms in OAB patients warrants further research.

Related Concept Videos

Long-term Depression01:05

Long-term Depression

Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
33.2K
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
202
Anxiety: Overview01:18

Anxiety: Overview

Anxiety is a common mental disorder featuring excessive worry, fear, and apprehension, significantly affecting daily life. People with anxiety disorders experience persistent and intense anxiety, interrupting their everyday functioning.
Individuals with anxiety often experience a range of physical and emotional symptoms, including sweating, trembling, tachycardia, and disturbances in sleep patterns. These symptoms vary in intensity and frequency but are generally disruptive and distressing.
1.0K
Freezing Point Depression and Boiling Point Elevation03:12

Freezing Point Depression and Boiling Point Elevation

Boiling Point Elevation
The boiling point of a liquid is the temperature at which its vapor pressure is equal to ambient atmospheric pressure. Since the vapor pressure of a solution is lowered due to the presence of nonvolatile solutes, it stands to reason that the solution’s boiling point will subsequently be increased. Vapor pressure increases with temperature, and so a solution will require a higher temperature than will pure solvent to achieve any given vapor pressure, including one...
39.9K
Depressants01:28

Depressants

Depressant drugs, including alcohol and sedative-hypnotics, diminish central nervous system activity by enhancing the action of gamma-aminobutyric acid (GABA), a neurotransmitter that reduces brain activity and promotes relaxation. These substances can have various therapeutic uses but also pose significant risks, especially when misused or combined.
Alcohol is a common depressant that can induce a sense of relaxation and reduced inhibition at low doses. Contrary to its occasional...
418
Generalized Anxiety Disorder01:30

Generalized Anxiety Disorder

Generalized Anxiety Disorder (GAD) is a chronic condition characterized by excessive and uncontrollable worry that persists for at least six months, significantly interfering with daily functioning. Unlike situational anxiety, which arises in response to specific stressors, GAD often occurs without a clear cause. Individuals may experience disproportionate worry about work, health, or relationships. For instance, a person might continuously fear poor health despite normal medical evaluations or...
685